Related Experiment Video
Updated: Jun 16, 2026
07:08
Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
Published on: February 2, 2024
Advanced pancreatic carcinoma: current treatment and future challenges
Anastasios Stathis1, Malcolm J Moore
1Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Hospital, University of Toronto, Toronto, ON M5G 2M9, Canada.
Nature Reviews. Clinical Oncology
|January 27, 2010
Summary
Pancreatic cancer remains a lethal disease with poor outcomes for advanced cases. Research is exploring molecular targets to overcome treatment resistance and improve survival rates for pancreatic adenocarcinoma.
Area of Science:
- Oncology
- Cancer Research
- Medical Science
Background:
- Pancreatic adenocarcinoma is a highly lethal solid tumor and a leading cause of cancer death.
- Most patients are diagnosed with advanced or metastatic disease, making curative surgery impossible.
- Current systemic treatments offer limited survival benefits for advanced pancreatic cancer.
Purpose of the Study:
- To review current standards of care for locally advanced and metastatic pancreatic carcinoma.
- To explore insights from preclinical research into molecular mechanisms of pancreatic cancer.
- To outline future directions for developing novel treatment strategies.
Main Methods:
- Review of current clinical standards of care.
- Analysis of preclinical laboratory investigations into molecular mechanisms.
- Synthesis of research findings to identify future therapeutic targets.
Main Results:
- Current therapies have not significantly improved survival for most patients with advanced pancreatic cancer.
- Preclinical studies have identified key molecular mechanisms driving pancreatic cancer development and treatment resistance.
- New targeted agents show promise in overcoming resistance and improving outcomes.
Conclusions:
- Despite challenges, advances in understanding molecular mechanisms offer optimism for improved pancreatic cancer treatment.
- Targeted therapies hold potential to overcome resistance and enhance outcomes for patients with advanced disease.
- Future research should focus on developing and testing novel agents based on molecular insights.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:30Acute Pancreatitis II: Clinical Manifestations and Management
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...